Navigation Links
Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
Date:9/23/2010

s, 2009-15 84

Operating costs and profit analysis, 2009-15 85

Chapter 7 Key products 87

Key findings 87

Overview 88

Xarelto 89

Summary 89

Sales forecast 90

US launch forecast at the end of 2010 90

Set to revolutionize anticoagulant management 90

Attractive product profile will aid market success 91

Regulatory hurdles remain 91

Invega franchise 93

Summary 93

Sales forecast 94

Limited switching from Risperdal 94

Invega Sustenna will build upon Risperdal Consta's success 95

Generic Invega assumed from 2012 95

Simponi 96

Summary 96

Sales forecast 97

Velcade 98

Summary 98

Sales forecast 99

Growth driven by label expansion 99

Takeda prevented J&J from acquiring Millennium 100

Remicade 101

Summary 101

Sales forecast 102

J&J markets Remicade in the US only 102

Humira has slowed growth of Remicade sales 102

New launches will maintain the growth of J&J's I&I franchise 103

Procrit 104

Summary 104

Sales forecast 105

Decline as market share lost to Aranesp from 2002 105

Safety concerns have hit the wider ESA market 105

Further competition limited to ex-US markets for now 106

Risperdal franchise 107

Summary 107

Sales forecast 108

Success driven by first to market and favorable side effect profile 108

US generics hit Risperdal sales from June 2008 109

Additional products aimed at retaining patients within JNJ's portfolio 109

Prezista 111

Summary 111

Sales forecast 112

Growth strengthened by earlier use 112

Close fit with additional HIV products 112

Chapter 8 Appendix 114

R&D pipeline 114

Remicade sales reconciliation 116

References 116

Abbreviations 117

Exchange rates 118

About Datam
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile
2. Reportlinker Adds Genzyme Corporation: PharmaVitae Profile
3. Reportlinker Adds Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
4. Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets
5. Reportlinker Adds Actelion Ltd: PharmaVitae Profile
6. Reportlinker Adds Pfizer Inc.: PharmaVitae Profile
7. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
8. Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile
9. Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
10. Reportlinker Adds The Impact of US Healthcare Reform on Pharma: Analyzing the Effects
11. Reportlinker Adds IP Overview - "Monoclonal Antibodies against digestive system cancers" Patent Landscape 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)... , August 28, 2014 ... titled, "DNA diagnostics Market (products, applications, techniques, end ... Opportunities, Growth and Forecast, 2013 - 2020," indicates ... $19 billion by 2020 registering a CAGR of ... provide accurate diagnosis and cost effectiveness over alternative ...
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced ... 9 th Annual Global Pharma Manufacturing Summit ... 8-9 th . The Global Pharma Manufacturing Summit ... small molecule and biologic pharmaceutical manufacturing. The conference ... today,s manufacturers face, such as the increasing pressure ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... -- China Health Resource, Inc. (OTCBB: CHRI), today announced results ... the first quarter of 2012. Revenues for ... increase of 234% over revenues of US $10,282,207 for 2010. For ... common share, compared with a net income of $2,707,286, or ...
... Oncos Therapeutics today announced the successful initiation ... adenovirus suggested as a potential new treatment for many types ... safety assessment part of the study. " We ... r thern Europe to start a clinical study with ...
Cached Medicine Technology:China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012 2China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012 3Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers 2
(Date:8/29/2014)... 29, 2014 Top10BestSEOHosting.com today compares ... USA and announces that Bluehost ( http://www.bluehost.com/track/seohosts ), ... hosting companies for webmasters who want to buy ... cloud hosting) at affordable rates. , Bluehost is ... One of its features is that Bluehost provides ...
(Date:8/29/2014)... The Department of Health and Human ... for Food Safety and Applied Nutrition (CFSAN), awarded ... contract and the first two task orders: “FARM ... Enhancement (DME) for FARM VI” to the team ... objectives include:, ,     Upgrade FARM platform ...
(Date:8/29/2014)... Two Kelowna dentists are putting out a ... container filled with classroom materials, clinic supplies and even two ... , “I don’t think words can describe what ... She and her husband, Dr. Jonathan Visscher, both partners at ... of New Reality International’s (NRI) mission to build and raise ...
(Date:8/28/2014)... 2014 When David Gergen, President of ... of Mark Brnovich, was asked to publicly support Mr. ... the Attorney General seat in the State of Arizona, ... support of Cardinal Hall of Fame wide receiver Roy ... and Mark Walczak. Green, Kennard and Walczak are members ...
(Date:8/28/2014)... 2014 Starting on Monday, the ... to accept donations in Bitcoin, in addition to all ... can be found at http://www.curemeso.org/bitcoin . , ... a form of payment, we decided it was important ... chief executive officer, Melinda Kotzian. , Bitcoin is ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: Bluehost, Arvixe, and Hostgator Are the Best Windows Web Hosting from the USA in 2014 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 3Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 2Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 3Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2
... (HealthDay News) -- Researchers have identified five new genes that ... coronary artery disease -- the most common cause of premature ... study. The international consortium said their discovery could ... treatments for the condition. In conducting the study, published ...
... Disease Alliance (ECDA)1 welcomes the UN High Level Meeting on ... "It is a memorable day in the history of ... gives a strong sense of the burden it represents to ... for all nations in the world2", declared Professor Michel Komajda, ...
... FRIDAY, Sept. 23 (HealthDay News) -- In large and diverse ... stick together, establishing both friendships and romantic relationships with ... people have in who they become close to, the researchers ... prefer to make friends with others who are similar to ...
... 22 (HealthDay News) -- A cardiac rehabilitation program appeared ... second stroke among patients who have suffered mild strokes ... researchers have found. "Overall, following the cardiac rehab ... in their risk profile," study senior investigator Neville Suskin, ...
... calcium-sensitizing drug levosimendan may be effective in improving ... which often accompanies chronic diseases such as chronic ... according to researchers in the Netherlands, who studied ... The drug, which is normally prescribed in patients ...
... , THURSDAY, Sept. 22 (HealthDay News) -- A new ... develop acute leukemia than whites. But if they do become ... know the reason for the disparity, but now that we ... study lead researcher Dr. Manali I. Patel, postdoctoral fellow in ...
Cached Medicine News:Health News:Scientists ID More Genes Linked to Heart Disease 2Health News:Non-communicable diseases at the center of UN discussions 2Health News:People Tend to Choose Friends Just Like Themselves 2Health News:Cardiac Rehab May Cut Risk Factors After Mini-Stroke 2Health News:Heart drug offers possible treatment for patients facing respiratory failure 2Health News:Heart drug offers possible treatment for patients facing respiratory failure 3Health News:Death Rate Higher in Minorities With Acute Leukemia 2
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Interseal acetabular cup system addresses the contemporary issues of the two-piece cementless acetabular component design....
... Alfa acetabular cup system has been designed ... a tri-spiked and cluster hole configurations. The ... minimize micromotion on three primary modes: Tilt, ... design features result in initial and long-term ...
Optimal solution for normal acetabulum....
Medicine Products: